Mankyu Park

Direttore/Membro del Consiglio presso

Coagulant Therapeutics, Inc.

Consumer Services

Finance

Health Technology

Profilo

Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.

Posizioni attive di Mankyu Park

Società	Posizione	Inizio
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Mankyu Park

Precedenti posizioni note di Mankyu Park

Società	Posizione	Fine
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mankyu Park

Formazione di Mankyu Park

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Mankyu Park

Società collegate

Aziende private	3
Goizueta Business School-Emory Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Finance
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Health Technology